AMERICAN HEART JOURNAL

American Heart Journal has been a trusted resource for cardiologists and general practice physicians for more than 70 years. Now under new editorship, the Journal has refocused its content to respond to the information needs of the cardiology community. In addition to publishing results of important clinical investigations, the Journal addresses such topics as cost-effectiveness, design of clinical trials, reports of negative clinical trials, and the changing organization of medical care. A new feature - AHJ at the Meetings - reports the key findings from major cardiovascular meetings, providing readers with ready access to the most recent clinical research data. Read and respected throughout the world, American Heart Journal ranks in the top 3.7% of the 4,625 scientific journals most frequently cited ( Science Citation Index ).The American Heart Journal will consider for publication suitable articles on topics pertaining to the broad discipline of cardiovascular disease. Our goal is to provide the reader primary investigation, scholarly review, and opinion concerning the practice of cardiovascular medicine. We especially encourage submission of 3 types of reports that are not frequently seen in cardiovascular journals: negative clinical studies, reports on study designs, and studies involving the organization of medical care. The Journal does not accept individual case reports or original articles involving bench laboratory or animal research.

《美国心脏杂志》作为心脏病学家和全科医生的可靠资源已有70多年的历史。现在，在新编辑的领导下，该杂志已重新调整其内容，以响应心脏病学社区的信息需求。除了发表重要的临床调查结果，该杂志还讨论了诸如成本效益、临床试验设计、阴性临床试验报告和不断变化的医疗组织等主题。一个新功能- AHJ在会议上报告主要心血管会议的关键发现，为读者提供了最新的临床研究数据。在4625种最常被引用的科学期刊(科学引文索引)中，《美国心脏杂志》排名前3.7%，在世界范围内受到广泛阅读和尊重。《美国心脏杂志》将考虑发表与心血管疾病这一广泛学科相关的合适文章。我们的目标是为读者提供关于心血管医学实践的初步调查、学术评论和意见。我们特别鼓励提交三种在心血管杂志上不常见的报告:负面临床研究、研究设计报告和涉及医疗组织的研究。本杂志不接受个别病例报告或涉及实验室或动物研究的原创文章。